Plasma brain natriuretic peptide levels indicate the distance from decompensated heart failure.
نویسندگان
چکیده
the Distance From Decompensated Heart Failure To the Editor: We read with great interest the recent article by Tang et al1 on plasma brain natriuretic peptide (BNP) levels in ambulatory patients with established chronic symptomatic systolic heart failure. They concluded that both symptomatic and asymptomatic patients present with a wide range of plasma BNP levels and that this heterogeneity may preclude the use of plasma BNP levels for deciding therapy and monitoring response. We agree with the analysis of their results; however, we disagree with their interpretation. BNP increases not only in response to pressure or volume loads, but also in response to neurohumoral factors and cytokines, independently of hemodynamic load. The clinical implications of increased plasma BNP levels differ depending on the underlying condition. For example, elevated BNP levels can mean increased filling pressure in dilated cardiomyopathy,2 the development of ventricular remodeling in myocardial infarction of recent onset,3 and left ventricular hypertrophy in hypertension.4 Plasma BNP levels are also influenced by many factors, including age, renal function, and arrhythmias. Because heart failure has diverse causes and patients have various clinical characteristics, we must analyze the meaning of increased BNP levels in individual patients. Nevertheless, measurement of plasma BNP remains important in heart failure, because decompensated heart failure does not occur in the absence of elevated plasma BNP levels. In patients with heart failure, symptoms are often very subjective and unrelated to cardiac status. Exercise capacity in heart failure is known not to correlate with cardiac function. In contrast, plasma BNP is secreted mainly from the ventricles and correlates with cardiac indices in heart disease; BNP markedly increases in decompensated heart failure.5 Thus, it seems reasonable to assume that the plasma BNP level in heart failure is inversely related to the distance from decompensated heart failure. For example, in patients with low BNP levels, the distance from decompensated heart failure is far; such patients are at low risk for the development of decompensated heart failure. In patients with high BNP levels, the distance is very close to decompensated heart failure, which easily develops even without symptoms. Intensive medical therapy should be considered in such patients. In patients with low BNP levels, including those with severe symptoms, intensive medical therapy would probably not be beneficial. Thus, medical therapy based solely on patients’ symptoms may be cost ineffective. Medical therapy based on the more objective indices such as plasma BNP levels is more likely to lead to a better outcome and more efficient use of valuable resources.
منابع مشابه
Evaluation of Brain Natriuretic Peptide plasma levels in children with Congenital Heart Diseases
ObjectiveThis study aimed to assess Brain Natriuretic Peptide in early diagnose of cardiac function in children with Congenital Heart Diseases.MethodologyThis study was performed on children with CHD and healthy. Severity of heart failure modified Ross classification system was used for grouping patients in four classes. For all participants, height, weight and head circumference were measured....
متن کاملEvaluation of Brain Natriuretic Peptide, Tumor Necrosis Factor and Interleukin-6 Plasma Levels in Infants and Children with Congenital Heart Disease
Background Congenital heart disease (CHD) is the most common cause of major congenital birth defect. The aim of this study was to investigate the association of CHD with serum levels of Tumor necrosis factor-α (TNFα), Interleukin 6 (IL-6), and B-type Natriuretic Peptide (BNP) in infant and children. Materials and Methods The present study was conducted in Heshmat heart hospital and 17 Shahrivar...
متن کاملPlasma interleukin-6 level is associated with NT-proBNP level and predicts short- and long-term mortality in patients with acute heart failure.
OBJECTIVES Interleukin 6 plays an important role in chronic heart failure (HF), but little is known about its involvement in acute decompensated heart failure (ADHF). The aim of our study is to evaluate the prognostic role of interleukin 6 (IL-6) in the patients with ADHF. METHODS Plasma levels of interleukin IL-6, N-terminal pro brain natriuretic peptide levels, and clinical covariates were ...
متن کاملEvaluation of Serum Levels of N-terminal Pro Brain Natriuretic Peptide and Atrial Natriuretic Peptide in Neonates with Respiratory Distress
Background: Acute respiratory distress (ARD) is a critical respiratory failure due to lung injury of neonates leading to the clinical appearance of poor lung compliance. The aimed of the study was to evaluate the diagnostic values in differentiating respiratory from heart diseases with using of N-terminal pro brain natriuretic peptide (NT-pro BNP) and Atrial natriuretic peptide(ANP) in neonates...
متن کاملClinical and Biochemical Assessments of Circulating B-Type Natriuretic Peptide as a Useful Marker in Pediatric Cardiac Patients
Background Although the left ventricle is the major site of BNP secretion in response to cardiac pressure or volume overload, the myocytes of both atria and ventricles secrete B- type natriuretic peptide (BNP). This study aimed to assess and compare the plasma levels of BNP in common pediatric cardiac diseases to clarify its pathophysiological role and evaluate its po...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Circulation
دوره 109 25 شماره
صفحات -
تاریخ انتشار 2004